See more : Nordea Invest Basis 3 (NDIB3KL1.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Vikas Lifecare Limited (VIKASLIFE.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vikas Lifecare Limited, a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
- Shougang Fushan Resources Group Limited (0639.HK) Income Statement Analysis – Financial Results
- Pan Asia Chemical Co. (4707.TWO) Income Statement Analysis – Financial Results
- Polson Limited (POLSON.BO) Income Statement Analysis – Financial Results
- Grupo TMM, S.A.B. (GTMAY) Income Statement Analysis – Financial Results
- Kolon TissueGene, Inc. (950160.KQ) Income Statement Analysis – Financial Results
Vikas Lifecare Limited (VIKASLIFE.NS)
About Vikas Lifecare Limited
Vikas Lifecare Limited engages in the trading of various chemicals compounds, polymers, PVC resins, plastic granules, and products related to plastic industry in India. It operates through Real Estate, Trading- Polymers, Trading-Cashew Nuts, and Manufacturing divisions. The company is also involved in the real estate business; and the manufacture of recycled material for automotive, packaging, sheathing, and textile industries. In addition, it manufactures and sells polymer compounds, which include PE, PVC, V blend SOE, and polypropylene compounds, as well as thermo plastic rubber; deals in FMCG, cashew nuts, aluminum foils, and processed food products. Vikas Lifecare Limited also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. Vikas Lifecare Limited was incorporated in 1995 and is based in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.46B | 4.76B | 3.01B | 749.95M | 1.55B | 2.13B | 667.42M | 1.01B | 933.26M | 811.09M |
| Cost of Revenue | 4.20B | 4.52B | 2.91B | 637.59M | 1.42B | 2.01B | 656.46M | 990.76M | 908.99M | 788.65M |
| Gross Profit | 262.04M | 243.20M | 101.59M | 112.35M | 135.40M | 121.71M | 10.96M | 14.66M | 24.27M | 22.44M |
| Gross Profit Ratio | 5.88% | 5.11% | 3.38% | 14.98% | 8.73% | 5.71% | 1.64% | 1.46% | 2.60% | 2.77% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 66.18M | 14.68M | 45.79M | 9.43M | 5.90M | 5.71M | 1.98M | 919.57K | 1.12M | 747.87K |
| Selling & Marketing | 1.61M | 2.10M | 439.00K | 2.51M | 4.49M | 5.52M | 0.00 | 2.26M | 2.05M | 925.36K |
| SG&A | 67.80M | 16.77M | 46.23M | 11.94M | 10.39M | 11.23M | 1.98M | 3.18M | 3.17M | 1.67M |
| Other Expenses | 0.00 | -278.61M | 6.45M | 4.30M | 12.25M | 11.00M | 35.66M | 9.96M | 6.80M | 6.83M |
| Operating Expenses | 67.80M | 155.66M | 122.39M | 41.48M | 49.97M | 62.09M | 19.23M | 9.37M | 9.97M | 8.50M |
| Cost & Expenses | 4.26B | 4.67B | 3.03B | 679.07M | 1.47B | 2.07B | 675.68M | 1.00B | 918.96M | 797.15M |
| Interest Income | 5.22M | 9.34M | 5.91M | 2.40M | 8.61M | 3.75M | 6.93M | 887.03K | 912.93K | 5.37M |
| Interest Expense | 28.66M | 23.02M | 13.77M | 38.85M | 48.81M | 53.80M | 26.74M | 13.29M | 14.31M | 11.30M |
| Depreciation & Amortization | 36.46M | 30.09M | 15.12M | 6.84M | 7.42M | 5.00M | 8.05M | 3.23M | 1.62M | 2.50M |
| EBITDA | 240.93M | -160.98M | 427.24M | 43.39M | 105.03M | 94.24M | 77.36M | 18.49M | 24.70M | 18.69M |
| EBITDA Ratio | 5.41% | -3.37% | 0.17% | 9.76% | 7.89% | 4.62% | 6.45% | 1.87% | 1.72% | 2.14% |
| Operating Income | 194.24M | -190.65M | -24.57M | 70.88M | 85.43M | 59.62M | -8.26M | 5.30M | 14.30M | 13.94M |
| Operating Income Ratio | 4.36% | -4.00% | -0.82% | 9.45% | 5.51% | 2.80% | -1.24% | 0.53% | 1.53% | 1.72% |
| Total Other Income/Expenses | -23.41M | 85.81M | 312.07M | -85.88M | -70.12M | -91.37M | -12.59M | -14.35M | -5.85M | -9.05M |
| Income Before Tax | 170.83M | -213.67M | 390.85M | -15.00M | 25.06M | 28.06M | 7.51M | 8.50M | 8.45M | 4.89M |
| Income Before Tax Ratio | 3.83% | -4.49% | 12.99% | -2.00% | 1.62% | 1.32% | 1.13% | 0.85% | 0.91% | 0.60% |
| Income Tax Expense | 36.29M | -58.57M | 101.39M | 20.02M | 11.09M | 8.80M | 1.84M | 1.65M | 1.41M | 697.95K |
| Net Income | 140.29M | -152.99M | 286.99M | -35.02M | 13.97M | 19.26M | 5.67M | 6.85M | 7.04M | 4.20M |
| Net Income Ratio | 3.15% | -3.21% | 9.54% | -4.67% | 0.90% | 0.90% | 0.85% | 0.68% | 0.75% | 0.52% |
| EPS | 0.10 | -0.12 | 0.31 | -0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.09 | -0.12 | 0.31 | -0.04 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 |
| Weighted Avg Shares Out | 1.47B | 1.31B | 934.41M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M |
| Weighted Avg Shares Out (Dil) | 1.53B | 1.31B | 934.41M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M | 795.50M |
Source: https://incomestatements.info
Category: Stock Reports